武汉佰乐博生物技术有限公司
   
     
联系热线
  • 联系人:方经理
  • 电 话:027-65279366
  • 邮箱:products@biolabreagent.com
  • 地 址:武汉市东湖新技术开发区神墩四路666号C栋

Research Grade Sozinibercept

发表时间:2025-02-27

Research Grade Sozinibercept

一、中文名称:

Research Grade Sozinibercept,科研级Sozinibercept

二、产品描述

Sozinibercept 在血管生成研究中作用关键。探索肿瘤生长与转移机制时,它能特异性阻断 VEGFCVEGF - D VEGFR - 3 的结合,抑制肿瘤相关淋巴管生成。在乳腺癌模型中,使用它可降低肿瘤细胞通过淋巴管转移的几率,为肿瘤转移防治策略研究提供依据。在眼科疾病研究方面,针对湿性年龄相关性黄斑变性(wAMD)的研究显示,Sozinibercept 能抑制脉络膜新生血管形成,调节相关信号通路,减少新生血管,为 wAMD 治疗方法探索提供新方向。在伤口愈合研究中,Sozinibercept 参与调节血管新生和重塑。在皮肤创伤模型实验中,使用它可使伤口处血管生成更有序,促进伤口快速愈合,为理解组织修复机制提供思路。

三、产品详情

名称:Research Grade Sozinibercept,科研级Sozinibercept

货号:DHE70402

表达系统:Mammalian Cells

种属反应性:Human

同种型:Vascular Endothelial Growth Factor Receptor 3 fusion protein with IgG1 Fc Fragment.

克隆类型:Monoclonal

靶标:Vascular endothelial growth factor C, VEGFC, Flt4-L, VEGF-C, Vascular endothelial growth factor-related protein, VRP, Flt4 ligand, Vascular endothelial growth factor D, VEGF-D, FIGF, VEGFD, c-Fos-induced growth factor

浓度:1 mg/ml

内毒素水平:Please contact with the lab for this information.

纯度:>95% as determined by SDS-PAGE.

纯化方式:Protein A/G purified from cell culture supernatant.

Accession 号:P49767 & O43915

克隆号:Sozinibercept

应用:Research Grade Biosimilar

状态:Liquid

保存溶液:0.01M PBS, pH 7.4.

稳定性和存储:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

别名:OPT-302, soluble VEGFR-3, sozinibercept, VGX-300

四、参考文献:

Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III Study.PMID:38942386

Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.PMID:38336282

Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.PMID:38280653

Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.PMID:38847896

Efficacy of Intravitreal Injections Anti-Vascular Endothelial Growth Factor Treatment for Radiation Retinopathy: A Systematic Review and Meta-analysis.PMID:38458409

详情请咨询Antibodysystem中国授权总代理-武汉佰乐博生物技术有限公司

网址:https://www.biolabreagent.com/product/99/5005.html

武汉佰乐博生物技术有限公司作为法国Antibodysystem品牌亚洲区授权总代理。提供近3万种蛋白、抗体等核心生命科学试剂,旨在为生命科学科研工作者提供专业、全面、可靠的试剂产品。

试剂 | 耗材 | 定制 | 实验服务 | 供应链

免费热线:027-65279366 /18108604356

联系方式
手机:18108604356
微信扫一扫